Lotus Technology (NASDAQ:LOT) Stock, Quote.Headers.trade-ideas

Lotus Technology

Lotus Technology Inc is a battery electric vehicle (BEV) maker that designs, develops, and sells BEV lifestyle vehicles under the Lotus brand. The Group is also a distributor that sells luxury sports cars under the Lotus brand. It also provides other sales and ancillary services to customers.

movers image

CCCC

MEOH

MERC

Methanex, Merck And Other Big Stocks Moving Lower In Monday&#39;s Pre-Market Session

Movers

News

Pre-Market Outlook

Trading Ideas

AUMN

BENF

BMRA

BURU

EAST

FEMY

Intelligent Bio Solutions Inc. - Common Stock

INBS

LIFW

MULN

SMMT

SVRA

TNXP

WHLR

Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Asia

Penny Stocks

Small Cap

Markets

MBLY

Key Takeaways:


	Ecarx’s revenue grew 31% in the second quarter, apparently driven by sales to brands owned by its controlling shareholder Geely
	The company’s heavy reliance on Geely and its subsidiaries leaves it vulnerable if ties between the two weaken


By Warren Yang

Growing Ecarx Tries, But Struggles, To Drive Away From Geely

Lotus Technology Inc. - American Depositary Shares

Lotus Technology Inc

LOTUS BAKERIES UNSP/ADR by Lotus Bakeries NV

Lotus Bakeries NV

Lot78 Inc

Lotto

Macro Notification

WIIM

General

SPDR Dow Jones Industrial Average ETF Trust

Major indexes are higher after the Federal Reserve cut interest rates by 50 basis points.

<a href="https://www.federalreserve.gov/newsevents/pressreleases/monetary20240918a.htm" title="https://www.federalreserve.gov/newsevents/pressreleases/monetary20240918a.htm">https://www.federalreserve.gov/newsevents/pressreleases/monetary20240918a.htm</a>

Federal Reserve

Analyst Ratings

Where Electronic Arts Stands With Analysts

$BTC

Fed Cuts Key Overnight Rate By 50 bps

BIIB

Biogen Executive Says Company Expects Immunogenicity Data To Be Ready By October To Submit To FDA for Subcutaneous Leqembi Filing

CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) shares are<a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener"> trading lower on Wednesday.</a>
The company has introduced AI Security Posture Management (AI-SPM) and announced the general availability of Data Security Posture Management (DSPM) as integrated features of <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40923437/crowdstrike-unveils-falcon-cloud-security-innovations-to-unify-protection-across-cloud-infrastruct" rel="noreferrer noopener">CrowdStrike Falcon Cloud Security.</a>
These advancements position Falcon Cloud Security as the sole CNAPP, providing comprehensive visibility and protection for cloud infrastructure, applications, data, and AI models from a single, unified platform.
New innovations to Falcon Cloud Security and Falcon Identity Protection include AI Security Posture Management, Data Security Posture Management, Falcon Privileged Access, and Real-Time Threat Protection for Microsoft Entra ID.
&#8220;As organizations increasingly adopt hybrid cloud and AI strategies to fuel their growth, they also introduce more complexity and gaps that adversaries exploit, leading to greater risk and potential compromise,&#8221; said Michael Sentonas, president, CrowdStrike.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/40915550/crowdstrike-partners-with-dazz-to-streamline-cloud-security-launches-financial-services-subsidia" rel="noreferrer noopener">CrowdStrike Partners With Dazz To Streamline Cloud Security; Launches Financial Services Subsidiary</a>
&#8220;The only way to see and secure every attack path is to unify workflows on a single console that stops breaches across the entire cloud estate,&#8221; Sentonas added.
Yesterday, the company disclosed a partnership with&nbsp;Dazz to strengthen visibility and protection within CrowdStrike Falcon Cloud Security by incorporating&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/ac40907669/crowdstrike-and-dazz-partner-to-automate-cloud-based-code-fixes" rel="noreferrer noopener">Dazz&#8217;s security remediation insights</a>.
This integration provides developer and infrastructure teams with enhanced cloud security, offering actionable recommendations for code fixes and remediation.
Price Action: CRWD shares are trading lower by 0.42% to $267.58 at last check Wednesday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40714383/crowdstrike-faces-short-term-challenges-like-pipeline-delays-deal-scrutiny-and-discounting-pressure" target="_blank" rel="noreferrer noopener">CrowdStrike Faces Short-Term Challenges Like Pipeline Delays, Deal Scrutiny, and Discounting Pressure, Analyst Says</a></li>
</ul>

Equities

CRWD

CrowdStrike Launches AI Security Posture Management To Enhance Cloud Protection

DA Davidson analyst Peter Heckmann maintains Envestnet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENV#NYSE">ENV</a>) with a Neutral and maintains $63 price target.

Price Target

DA Davidson Maintains Neutral on Envestnet, Maintains $63 Price Target

DA Davidson analyst Rudy Kessinger maintains CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Buy and maintains $310 price target.

DA Davidson Maintains Buy on CrowdStrike Holdings, Maintains $310 Price Target

Politics

Teamsters Union Says Poll Of Members Show 58% Supported Trump Compared With 31% For Harris

FedEx Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) will release earnings results for its first quarter, after the <a href="https://www.benzinga.com/quote/FDX/earnings">closing bell on Thursday, Sept. 19</a>.
Analysts expect the company to report quarterly earnings at $4.83 per share, up from $4.55 per share in the year-ago period. The company projects to report revenue of $21.99 billion for the quarter, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Sept. 6, the Equal Employment Opportunity Commission (EEOC) sued FedEx, saying the global shipping and logistics company violated federal law by discriminating against its <a href="https://www.benzinga.com/24/09/40776831/fedex-faces-lawsuit-over-alleged-discrimination-against-disabled-drivers">employees with disabilities.</a>
FedEx shares rose 1.6% to close at $297.34 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/TJX/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587f78ce77f9dd000126ef08/jonathan-chappell">Evercore ISI Group analyst Jonathan Chappell</a> maintained an Outperform rating and cut the price target from $339 to $335 on Sept. 12. This analyst has an accuracy rate of 73%.</li>
<li>Argus Research analyst John Eade maintained a Buy rating and raised the price target from $325 to $335 on June 27. This analyst has an accuracy rate of 74%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/597a27c4c1f5580001ef5088/patrick-tyler%20brown">Raymond James analyst Patrick Tyler Brown </a>maintained an Outperform rating and boosted the price target from $300 to $335 on June 26. This analyst has an accuracy rate of 80%.</li>
<li>Wells Fargo analyst Christian Wetherbee maintained an Equal-Weight rating and raised the price target from $275 to $300 on June 26. This analyst has an accuracy rate of 74%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e734b395f2b9b00011504b0/daniel-imbro">Stephens &amp; Co. analyst Daniel Imbro</a> reiterated an Overweight rating with a price target of $325 on June 26. This analyst has an accuracy rate of 78%.</li>
</ul>
Considering buying FDX stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="525" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/18032422/image-134-1024x525.png" alt="" class="wp-image-553211" style="width:556px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/18032422/image-134-1024x525.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/18032422/image-134-300x154.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/18032422/image-134-768x393.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/18032422/image-134.png 1310w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:
<ul>
<li><a href="https://www.benzinga.com/24/09/40898216/cramer-hewlett-packard-is-a-very-inexpensive-stock-likes-this-big-tech-stock"> Cramer: Hewlett Packard Is A &#8216;Very Inexpensive&#8217; Stock, Likes This Big Tech Stock</a></li>
</ul>

Earnings

FedEx Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

DA Davidson analyst Rudy Kessinger maintains Confluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) with a Buy and maintains $30 price target.

CFLT

DA Davidson Maintains Buy on Confluent, Maintains $30 Price Target

Guidance

TMUS

T-Mobile Expects Service Revenue Of $75B To $76B And Adjusted Free Cash Flow Of $18B To $19B In 2027; TFB Anticipated To Deliver Double-Digit Growth, With Overall Service Revenue CAGR Of 5% From 2023-2027

Keefe, Bruyette &amp; Woods analyst Sanjay Sakhrani maintains PayPal Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) with a Outperform and maintains $78 price target.

PYPL

Keefe, Bruyette & Woods Maintains Outperform on PayPal Holdings, Maintains $78 Price Target

Novartis (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nvs#NYSE">NVS</a>) announced that the FDA has approved breast cancer drug Kisqali (ribociclib) for a broader population.
The regulatory body approved Kisqali in combination with an aromatase inhibitor for the adjuvant treatment of people with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) stage II and III early breast cancer (EBC) at high risk of recurrence, including those with node-negative (N0) disease.
Kisqali is a selective cyclin-dependent kinase inhibitor, a class of drugs that helps slow the progression of cancer by inhibiting two proteins &mdash; cyclin-dependent kinase 4 and 6 (CDK4/6).
The broad indication in HR+/HER2- stage II and III EBC at high risk of recurrence approximately doubles the population eligible for CDK4/6 inhibitor adjuvant therapy.
Year to date, shares of Novartis have risen 14.6% compared with the industry&#39;s growth of 24.1%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/e0/78240.jpg?v=1246149801" /> 
Image Source: Zacks Investment Research
<h2>Broader Label for NVS&#39; Kisqali</h2>
The FDA approval is based on strong results from the late-stage NATALEE trial. The results showed a significant and clinically meaningful 25.1% reduction in risk of disease recurrence in a broad population of patients with HR+/HER2- stage II and III EBC treated with adjuvant Kisqali plus endocrine therapy&nbsp;compared to ET alone, including those with high-risk N0 disease.
The invasive disease-free survival benefit was consistently observed across all patient subgroups.
Please note that Kisqali is already approved for the treatment of metastatic breast cancer (MBC) in several countries.
The latest FDA approval of Kisqali for this early breast cancer population, including those with N0 disease, should enable NVS to offer treatment with a CDK4/6 inhibitor to a significantly broader group of patients.
NVS recently presented an updated analysis from the NATALEE trial at the European Society for Medical Oncology Congress 2024. Results showed that Kisqali caused a deepening benefit beyond the three-year treatment period and reduced the risk of recurrence by 28.5% compared to ET alone, in patients with stage II and III HR+/HER2- EBC.
Novartis will continue to evaluate NATALEE patients for long-term outcomes, including overall survival.
<h2>Kisqali: A Top Drug for NVS</h2>
Kisqali is one of the key growth drivers for NVS, which is now a pure-play innovative medicine company with a focus on core therapeutic areas &mdash; cardiovascular, renal and metabolic, immunology, neuroscience and oncology.
It is one of the leading breast cancer drugs in the United States and outside the country, with a dominant market share. The drug generated sales worth $1.3 billion in the first half of 2024.
Approximately 90% of breast cancer cases in the United States are diagnosed early (stages I-III). These patients remain at risk of cancer recurrence (in most cases as an incurable metastatic disease).
The drug&#39;s approval for a broader population should further fuel sales.
Regulatory reviews for Kisqali as an EBC treatment are ongoing worldwide, including in the EU and China.
Last year, the FDA also expanded Eli Lilly&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lly#NYSE">LLY</a>) Verzenio&#39;s (abemaciclib) indication. Verzenio, a CDK4/6 inhibitor, was approved in combination with ET for the adjuvant treatment of HR+HER2-, node-positive, EBC at a high risk of recurrence.
Eli Lilly is witnessing a stupendous run in 2024, riding high on the success of its GLP-1 drugs &mdash; Mounjaro and Zepbound.
<h2>NVS&#39; Zacks Rank &amp; A Stock to Consider</h2>
NVS currently carries a Zacks Rank #3 (Hold).
A better-ranked stock from the large-cap pharma industry is Pfizer, which currently sports a Zacks Rank #2 (Buy).
Estimates for PFE&#39;s 2024 earnings have risen from $2.39 to $2.62 per share over the past 60 days. For 2025, the bottom-line estimate has risen from $2.75 to $2.85 over the same time frame.
<a href="https://www.zacks.com/stock/news/2337925/novartis-wins-fda-approval-of-kisqali-for-early-breast-cancer?cid=CS-BENZ-FT-analyst_blog|company_news_medical_sector-2337925">To read this article on Zacks.com click here.</a>

Large Cap

Novartis Wins FDA Approval of Kisqali for Early Breast Cancer

T-Mobile Unveils T-Priority, Featuring World's First 5G Network Slice For First Responders, Offering Cutting-Edge Connectivity Solutions And Unmatched Support For Emergency Situations

American businessman and social media personality David Portnoy would like to see marijuana legalized in Florida. That's according to his post on social platform X this past weekend.
In a roughly one-minute video posted on Sunday, he urged Floridians to support Amendment 3 which is up for a vote statewide during the upcoming <a href="https://www.benzinga.com/topic/2024-election">November elections</a> and would legalize cannabis across the state, <a href="https://floridapolitics.com/archives/696152-wake-up-dave-portnoy-backs-floridas-recreational-pot-measure-riling-conservatives-online/">reported</a> Florida Politics.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/18124210/ccc-oct-24-banner__1_-28.gif" alt="" class="wp-image-554568" /></a></figure>
"As an adult, I should be allowed to smoke weed, watch football and eat pizza on Sunday regardless if I'm at home in Mass [Massachusetts] or Florida," Portnoy, who created a divisive "bro culture" empire with his <a href="https://www.benzinga.com/markets/cannabis/24/09/40924527/barstool-sports-expands-into-cannabis-industry-partners-with-green-thumb-industries">Barstool Sports </a>platform, wrote in the post, "Vote #YesOn3 in Florida on Nov 5th."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Breaking: As an adult, I should be allowed to smoke weed, watch football, and eat pizza on Sunday regardless if I'm at home in Mass or Florida. Vote <a href="https://twitter.com/hashtag/YesOn3?src=hash&amp;ref_src=twsrc%5Etfw">#YesOn3</a> in Florida on Nov 5th. <a href="https://t.co/pHXYu2e5LJ">pic.twitter.com/pHXYu2e5LJ</a>
&mdash; Dave Portnoy (@stoolpresidente) <a href="https://twitter.com/stoolpresidente/status/1835375264211042754?ref_src=twsrc%5Etfw">September 15, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Also: <a href="https://www.benzinga.com/markets/cannabis/21/02/19427491/cbdmd-to-donate-up-to-500k-from-sales-to-portnoys-barstool-fund">CbdMD To Donate Up To $500K From Sales To Portnoy&#8217;s Barstool Fund</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
As of Wednesday morning, the video had over 22 million views, 83,000 likes, 6,900 shares and 6,500 comments.
"It's about freedom. Half the states allow this, legal marijuana," Portnoy said. "Florida, I want to be able to watch football, eat pizza and smoke. We're all adults here, 21-plus, make your own decisions. It's on the ballot. Vote ‘yes' on 3. Legalize recreational weed. Come on. Where are we, Florida? Wake up."
Portnoy's backing of marijuana reform comes on the heels of Donald Trump's endorsement of Amendment 3. Even though VP&nbsp;<a href="https://www.benzinga.com/topic/kamala-harris">Kamala Harris</a>‘s team called <a href="https://www.benzinga.com/markets/cannabis/24/09/40785015/harris-campaign-accuses-trump-of-blatant-pandering-and-lying-about-his-cannabis-support-announce">Trump&#8217;s new-found support of marijuana</a> to be &#8220;blatant pandering,&#8221; it's still noteworthy given his past tough <a href="https://www.benzinga.com/markets/cannabis/22/11/29741741/trump-announcement-death-to-drug-dealers-and-beautiful-american-flag-on-mars">stance on drug policy.&nbsp;</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/40923340/trump-says-yes-to-legal-cannabis-in-florida-but-hometown-palm-beach-says-no-thanks-to-weed-shops">Trump Says Yes To Legal Cannabis In Florida, But Hometown Palm Beach Says No Thanks To Weed Shops</a></li>
</ul>
Photo: Benzinga edit of images by Matthew Brodeur on Unsplash and Zach Catanzareti&nbsp;on <a href="https://commons.wikimedia.org/wiki/File:Dave_portnoy_(48571713636).jpg">Wikimedia Commons</a>

Cannabis

Government

Entrepreneurship

Legal

David Portnoy's Viral Push For Florida's Marijuana Amendment 3 Calls For Freedom To Smoke Weed, Eat Pizza, Watch Football

DA Davidson analyst Linda Bolton Weiser maintains e.l.f. Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) with a Buy and maintains $223 price target.

DA Davidson Maintains Buy on e.l.f. Beauty, Maintains $223 Price Target

Dividends

T-Mobile Announces 35% Increase In Quarterly Dividend To $0.88 Per Share, Payable December 12, 2024, To Stockholders Of Record On November 27, 2024

DA Davidson analyst Linda Bolton Weiser maintains Inter Parfums (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) with a Buy and maintains $163 price target.

IPAR

DA Davidson Maintains Buy on Inter Parfums, Maintains $163 Price Target

T-Mobile US, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) shares are <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading lower on Wednesday.</a>
The company has announced a partnership with NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Ericsson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERIC#NASDAQ">ERIC</a>), and Nokia Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOK#NYSE">NOK</a>) to shape the future of mobile <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40922877/t-mobile-announces-technology-partnership-with-nvidia-ericsson-and-nokia-to-advance-the-future-of-" rel="noreferrer noopener">networks by placing AI at the forefront.</a>
This collaboration will enhance the capabilities of radio access networks (RAN) in innovative ways to better serve customers.
&#8220;Just like T-Mobile led in 5G, we intend to lead in the next wave of network technology, for the benefit of our customers,&#8221; said Mike Sievert, CEO of T-Mobile.
By leveraging T-Mobile&#8217;s leadership in 5G, along with the expertise of NVIDIA, Ericsson, and Nokia in telecommunications solutions, the group, known as the founding members of the AI-RAN Alliance, is investing in an industry-first AI-RAN Innovation Center located in Bellevue, Washington.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40921827/fed-decision-is-here-5-things-investors-need-to-know-ahead-of-wednesdays-pivotal-in" rel="noreferrer noopener">Fed Decision Is Here: 5 Things Investors Need To Know Ahead Of Wednesday&#8217;s Pivotal Interest Rate Call</a>
&#8220;AI-RAN at T-Mobile will be all about unlocking the massive capacity and performance that customers increasingly demand from mobile networks,&#8221; the CEO said.
This center will focus on integrating RAN and AI advancements to create transformative network experiences for customers.
The CEO stated that the collaboration among T-Mobile, NVIDIA, Nokia, and Ericsson would shape the future of mobile networks in the 5G Advanced era and beyond, driving meaningful progress.
In a separate <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40922898/t-mobile-and-openai-join-forces-to-revolutionize-the-customer-experience-with-first-ever-intent-dr" rel="noreferrer noopener">release</a>, the company announced that it has inked a pact with OpenAI to revolutionize the customer experience and reset customer success benchmarks for companies worldwide. The two companies are custom-building the first intent-driven AI-decisioning platform of its kind, called IntentCX.
Price Action: TMUS shares are trading lower by 2.5% to $197.57 at last check Wednesday.
Photo by viewimage on Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40918078/is-the-fed-playing-with-fire-we-see-greater-risk-of-an-overheating-economy-as-they-" target="_blank" rel="noreferrer noopener">Is The Fed Playing With Fire? &#8216;We See Greater Risk Of An Overheating Economy&#8217; As They Cut Rates, Veteran Investor Warns</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

ERIC

NVDA

T-Mobile Partners with NVIDIA, Ericsson, And Nokia to Pioneer AI-Driven Mobile Networks

Big Lots sets another all-time low as risk of bankruptcy looms

SunCar Technology partners with Lotus Technology to expand sales and service network

New energy vehicles top 50% of all auto sales in China for the first time

Lotus Robotics to provide Lynk & Co's EV with intelligent driving technology

Lotus Technology says it re-emergence in the U.S. contributed to revenue doubling in Q2

Lotus Technology says its re-emergence in the U.S. contributed to revenue doubling in Q2

Lotus Technology reports Q2 results

Lotus Technology (LOT) has released an update. Lotus Technology has delivered a record-breaking performance in the first half of 2024, with a 239% ...

Lotus Tech Achieves Record Growth Amidst Adjustments

Lotus Technology to start Eletre deliveries in the GCC region in September

Lotus Technology (LOT) has released an update. Lotus Technology Inc. has entered into a Securities Purchase Agreement with Westwood Capital Group L...

Lotus Technology Inks Deal with Westwood Capital

BCCMY

BMWYY

BYDDF

BYDDY

DNFGY

GELYF

GNZUF

GWLLF

LCID

MBGAF

NSANY

TSLA

VLKAF

WLMTF

XPEV

Press Releases

Lotus Technology to Report Unaudited First Half 2024 Financial Results on August 28, 2024

Lotus Robotics Provides Intelligent Driving Solutions for Lynk&Co's First All-electric Sedan

Lotus Robotics Provides Intelligent Driving Solutions for New Energy Trucks and Vans

Lotus Technology Reports Unaudited Second Quarter and First Half 2024 Financial Results

Lotus Enters the GCC Region with Two Award Winning Models

Lotus Technology wins 2024 EUCCC Sustainable Business Award for Decarbonization Leadership

Lotus Eletre SUV Starts Delivery in North Asia

Lotus Robotics Selected to Supply to a World-Class Japanese Tier-One Supplier

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024

Lotus Revealed Groundbreaking Concept Car: A Leap into the Future of Automotive Design

BDOUY

BLTE

CRRFY

DSFIY

EDPFY

FPAFY

KKPNY

MAKSY

PARIS:CA

REPYY

SSEZY

VIOT

Thunder Power Holdings, Inc. - Common Stock

Thunder Power Holdings

Cenntro

ECD Automotive Design, Inc. - Common Stock

ECD Automotive Design

Envirotech Vehicles

Ford Motor

Faraday Future Intelligent Electric Inc. - Class A Common Stock

Faraday Future

General Motors

Canoo

Honda Motor Co

Lucid Gr

Li Auto Inc. - American Depositary Shares

Li Auto

Mullen Automotive

NIO Inc. American depositary shares, each representing one Class A ordinary share

NWTN

Polestar Automotive Holding UK Limited - Class A ADS

Polestar Automotive

Polestar Automotive Holding UK Limited - Class C-1 ADS (ADW)

Rivian Automotive, Inc. - Class A Common Stock

Rivian Automotive

Thor Industries

Toyota Motor

Tesla

VinFast Auto

Winnebago Industries

Workhorse Gr

XPeng Inc. American depositary shares, each representing two Class A ordinary shares

XPeng

ZEEKR Intelligent Technology Holding Limited American Depositary Shares (each representing ten (10) Ordinary Shares)

ZEEKR Intelligent Tech

Deutsche Bank

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Lotus Technology

Lotus Technology (LOT) Forecast

Lotus Technology (NASDAQ:LOT) Stock, Quote.Headers.trade-ideas